The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C

Liver

Volumn 17, Issue 5, 1997, Pages 215-223

  Shev, Steven ^a,b   Dhillon, Amar P ^c   Lindh, Magnus ^a   Serléus, Zita ^d   Wejstål, Rune ^a   Widell, Anders ^d   Norkrans, Gunnar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b VARBERG HOSPITAL   (Sweden)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol; Chronic; HBV DNA; HCV RNA; Hepatitis C; HGV RNA; Histology; Mild; Minimal; Prognosis

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; MALE;

EID: 0030671209     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb01021.x     Document Type: Article

References (37)

1. KUO G, CHOO Q-L, ALTER H J, et al An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989: 244: 362-364.
2. ALTER M J, MARGOLIS H S, KRAWCZYNSKI K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992: 327: 1899-1905.
3. WEJSTÅL R, WIDELL A, NORKRANS G. Hepatitis C virus infection with progression to hepatocellular carcinoma: a report of five prospectively followed patients in Sweden. Scand J Infect Dis 1993: 25: 417-420.
4. SEEFF L B, BUSKELL-BALES Z, WRIGHT E C, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992: 327: 1906-1911.
5. SIMMONDS P, HOLMES E C, CHA T-A, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993: 74: 2391-2399.
6. DE MITRI M S, POUSSIN K, BACCARINI P, et al. HCV associated liver cancer without cirrhosis. Lancet 1995: 345: 413-415.
7. DE GROOTE J, DESMET V J, GEDIGK P, et al. A classification of chronic hepatitis. Lancet 1968: 2: 626-628.
8. BECKER M D, BAPTISTA A, SCHEUER P J, et al. Prognosis of chronic persistent hepatitis. Lancet 1970: 1: 53-57.
9. VUCELIC B, HADZIC N, DUBRAVCIC D. Chronic persistent hepatitis - long-term prospective study on the natural course of the disease. Scand J Gastroenterol 1988: 23: 551-554.
10. WEJSTÅL R, HERMODSSON S, NORKRANS G. Long-term follow-up of chronic hepatitis non-A, non-B - with special reference to hepatitis C. Liver 1991: 11: 143-148.
11. HOPF U, MÖLLER B, KUTHER D, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990: 10: 69-76
12. TAKAHASHI M, YAMADA G, MIYAMOTO R, et al. Natural course of chronic hepatitis C. Am J Gastroenterol 1993: 88: 240-243.
13. YOUSUF M, NAKANO Y, TANAKA E, et al. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 1992: 27: 812-816.
14. VAQUER P, CANET R, LLOMPART A, et al. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994: 14: 265-269.
15. KNODELL R G, ISHAK K G, BLACK W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431-435.
16. DESMET V J, GERBER M, HOOFNAGLE J H, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994: 19: 1513-1520.
17. WIDELL A, MÅNSSON A-S, SUNDSTRÖM G, et al. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 1991: 35: 253-258.
18. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-679.
19. WIDELL A, SHEV S, MÅNSSON S, et al. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol 1994: 44: 272-279.
20. STUYVER L, ROSSAU R, WYSEUR A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993: 74: 1093-1102.
21. LINDH M, HORAL P, DHILLON A P, et al. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 1996: 24: 494-501.
22. LEARY T P, MUERHOFF A S, SIMONS J N, et al. Sequence and genomic organizaiton of GBV-C: a novel member of the Flaviviridae associated with human non A-E hepatitis. J Med Virol 1995: 48: 60-67.
23. LINNEN J, WAGES J, ZHANG-KECK Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996: 271: 505-508.
24. MATTSSON L, WEILAND O, GLAUMANN H. Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C. Liver 1990: 10: 257-263.
25. KIYOSAWA K, TANAKA E, SODEYAMA T, et al. Natural history of hepatitis C. Intervirology 1994: 37: 101-107.
26. SHEV S, FOBERG U, FRYDÉN A, et al. Second-generation hepatitis C ELISA antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors. Vox Sang 1993: 65: 32-37.
27. FONG T-L, KANEL G C, CONRAD A, et al. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994: 19: 554-557.
28. MIYAKAWA H, SATO C, IZUMI N, et al. Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma. Alcohol Alcohol 1993: 28 (S1A): 85-90.
29. SAWADA M, TAKADA A, TAKASE S, et al. Effects of alcohol on the replication of hepatitis C virus. Alcohol Alcohol 1993: 28 (S1B): 85-90.
30. GRETCH D, COREY L, WILSON J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994: 169: 1219-1225.
31. JILG W, SIEGER E, ZACHOVAL R, et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995: 23: 14-20.
32. MICHALAK T I, PASQUINELLI C, GUILHOT S, et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. Clin Invest 1994: 93: 230-239.
33. LIAW Y-F. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995: 22: 1101-1108.
34. TER BORG F, CHAMULEAU R A F M, REESINK H W, et al. Can liver histology be predicted from ALT and serum hepatitis B viral DNA measurements in HBsAg positive, anti-HBeAg-positive patients? J Hepatol 1995: 23 (Suppl. 1): S90 (abstract).
35. GORDON S C, ELLOWAY R S, LONG J C, et al. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 1993: 18: 1338-1343.
36. TONG M J, EL-FARRA N S, REIKES A R, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995: 332: 1463-1466.
37. SHEV S, WIDELL A, FOBERG U, et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995: 23: 253-257.